Drug and surfactant transport in Cyclosporine A and Brij 98 laden p-HEMA hydrogels

被引:78
作者
Kapoor, Yash [1 ]
Chauhan, Anuj [1 ]
机构
[1] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA
基金
美国国家科学基金会;
关键词
Cyclosporine A; p-HEMA; transport; model; micelles; aggregation; Brij; 98;
D O I
10.1016/j.jcis.2008.02.028
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Surfactants are commonly incorporated into hydrogels to increase solute loading and attenuate the release rates. In this paper we focus on understanding and modeling the mechanisms of both surfactant and drug transport in hydrogels. Specifically, we focus on Brij 98 as the surfactant, Cyclosporine A (CyA) as the hydrophobic drug, and poly-hydroxy ethyl methacrylate (p-HEMA) as the polymer. The models developed here are validated by experiments conducted with gels of different thicknesses and surfactant loadings. Also the model is compared with prior experimental studies in literature. The model predicts that the percentage surfactant as well as drug release scales as 1/(surfactant loading)(0.5), and thus a four fold increase in surfactant loading leads to a two fold reduction in percentage release for both drug and surfactant at a given time. The models for the surfactant and drug release are fitted to the experimental data to obtain values of 1.44 x 10(-14) m(2)/s for CyA diffusivity and 414.4 for the partition coefficient between drug concentration inside the micelle and that in the gel. These models can be very helpful in tuning the drug release rates from hydrogels by controlling the surfactant concentration. The results also show that Brij 98 loaded p-HEMA exhibit an extended release of CyA and so contact lenses made with this material can be used for extended ocular delivery of CyA, which is an immunosuppressant drug commonly used for treatment of various ocular ailments. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:624 / 633
页数:10
相关论文
共 13 条
[1]  
Alvarez-Lorenzo C., 2003, AM J DRUG DELIV, V1, P77
[2]   Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels [J].
Barreiro-Iglesias, R ;
Alvarez-Lorenzo, C ;
Concheiro, A .
JOURNAL OF CONTROLLED RELEASE, 2001, 77 (1-2) :59-75
[3]   The treatment of dry eye [J].
Calonge, M .
SURVEY OF OPHTHALMOLOGY, 2001, 45 :S227-S239
[4]   Relapsing Wegener's granulomatosis: Successful treatment with cyclosporin-A [J].
Georganas, C ;
Ioakimidis, D ;
Iatrou, C ;
Vidalaki, B ;
Iliadou, K ;
Athanassiou, P ;
Kontomerkos, T .
CLINICAL RHEUMATOLOGY, 1996, 15 (02) :189-192
[5]   Topical cyclosporin A in the management of vernal keratoconjunctivitis [J].
Gupta, V ;
Sahu, PK .
EYE, 2001, 15 (1) :39-41
[7]   Carbopol/pluronic phase change solutions for ophthalmic drug delivery [J].
Lin, HR ;
Sung, KC .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (03) :379-388
[8]   SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel [J].
Liu, JH ;
Li, L .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 (2-3) :237-244
[9]   Immobilization of camptothecin with surfactant into hydrogel for controlled drug release [J].
Liu, Jianhong ;
Li, Lin ;
Cai, Yiyu .
EUROPEAN POLYMER JOURNAL, 2006, 42 (08) :1767-1774
[10]   Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers [J].
Paulsson, M ;
Edsman, K .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2002, 248 (01) :194-200